ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Recent Registrations
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024 - 2025
April 2019 - 26 products
L IP  Ilumetri 200 mg/2 ml 2962.663238.5010 %Injection solution: Tildrakizumabum 200mg / 2mlAlmirall AGB / SLGtell a friend
L IPCI Xarelto vascular 2,5 mg5631.5650.4510 %Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGB / SL / SOGtell a friend
L IPCI Xarelto vascular 2,5 mg196110.49135.5510 %Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGB / SL / SOGtell a friend
  IPCI Fluoxetin Axapharm 20 mg309.6226.8510 %Coated tablets: Fluoxetinum 20 mgaxapharm agB / SL / SGGtell a friend
  IPCI Fluoxetin Axapharm 20 mg10035.2854.7010 %Coated tablets: Fluoxetinum 20 mgaxapharm agB / SL / SGGtell a friend
L IPCI Ilumetri 100 mg/1 ml 2962.663238.5010 %Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGB / SLGtell a friend
  IPCI Biktarvy301005.601110.0510 %Coated tablets: 3 Active AgentsGilead Sciences
Switzerland Sàrl		A / SLGtell a friend
  IPCI Biktarvy301005.601110.0510 %Coated tablets: 3 Active AgentsGilead Sciences
Switzerland Sàrl		A / SLGtell a friend
L IPCI Imbruvica 140 mg281410.331550.2510 %Coated tablets: Ibrutinibum 140 mgJanssen-Cilag AGA / SLGtell a friend
L IP  Imbruvica 280 mg282816.903079.9510 %Coated tablets: Ibrutinibum 280 mgJanssen-Cilag AGA / SLGtell a friend
L IP  Imbruvica 420 mg284232.574619.6010 %Coated tablets: Ibrutinibum 420 mgJanssen-Cilag AGA / SLGtell a friend
L IP  Imbruvica 560 mg285643.426097.9510 %Coated tablets: Ibrutinibum 560 mgJanssen-Cilag AGA / SLGtell a friend
  IPCI Spiolto Respimat 2.5 mcg / 2.5 mcg 46.8467.3510 %Lösung zur Inhalation (wiederverwendbar): 2 Active AgentsBoehringer Ingelheim
(Schweiz) GmbH		B / SLGtell a friend
  IPCI Spiolto Respimat 2.5 mcg / 2.5 mcg3140.52169.2510 %Lösung zur Inhalation (wiederverwendbar): 2 Active AgentsBoehringer Ingelheim
(Schweiz) GmbH		B / SLGtell a friend
L IP  Trazimera 150 mg 456.84513.2510 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mgPfizer AGA / SLGtell a friend
L IP  Trazimera 440 mg 1335.641469.0010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 440 mgPfizer AGA / SLGtell a friend
L IP  Skyrizi 150 mg 3085.453372.0510 %lnjektionslösung in einer Fertigspritze: Risankizumabum 150 mg/mlAbbVie AGB / SLGtell a friend
L IPCI Dupixent 300 mg/2 ml21065.681175.4010 %solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 300mg / 2mlSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
L IPCI Dupixent 200 mg/1.14 ml21065.681175.4010 %solution injectable en seringue préremplie avec système de sécurité: Dupilumabum 200mg / 1.14mlSanofi-Aventis
(Suisse) SA		B / SLGtell a friend
  IPCI Yescarta68 mlPRPRk.A.Axicabtagenum Ciloleucelum Zelldispersion von 0.4 – 2 X 10e8 Zellen/einzel-Infusionsbeutel (68 Ml)Gilead Sciences
Switzerland Sàrl		AGtell a friend
  IPCI Ilumetri 100 mg/1 ml2PRPRk.A.Injection solution: Tildrakizumabum 100 mg/mlAlmirall AGBGtell a friend
  IP  Nutryelt Junior 10 ml10 x 10 mlPRPRk.A.Concentrate for infusion: 5 Active AgentsBaxter AGBGtell a friend
  IPCI Otrivin Schnupfen Plus10 mlPRPRk.A.Nasal spray: 2 Active AgentsHaleon Schweiz AGDGtell a friend
  IPCI Xarelto vascular 2,5 mg30 x 1PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IPCI Xarelto vascular 2,5 mg100PRPRk.A.Coated tablets: Rivaroxabanum 2.5 mgBayer (Schweiz) AGBGtell a friend
  IPCI Skyrizi 75 mg23293.763622.10k.A.lnjektionslösung in einer Fertigspritze: Risankizumabum 75mg / 0.83mlAbbVie AGBGtell a friend
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home